KYBORA Life Sciences (Shanghai) Co., Ltd. Appoints Wang Zhi as Executive Vice President and Managing Director
SHANGHAI and PRINCETON, N.J. (PRWEB) June 09, 2023 -- KYBORA Life Sciences, a global advisory firm dedicated to facilitating enduring success for life sciences companies, is pleased to announce the appointment of Wang Zhi as Executive Vice President (EVP) and Managing Director of KYBORA Life Sciences (Shanghai) Co., Ltd., effective June 21, 2023.
Wang Zhi brings extensive experience and a proven track record in the pharmaceutical and life sciences industry to his new role. As EVP and Managing Director, Mr. Zhi will assume leadership of KYBORA's operations in Shanghai, overseeing the delivery of exceptional business and corporate development transaction services to clients worldwide. This encompassing portfolio includes M&A, licensing, fundraising, and strategic consulting services, which enable life sciences companies to navigate the complexities of the industry and achieve sustainable growth.
"We are delighted to welcome Mr. Zhi to the esteemed KYBORA team," said Alan Vanderborght, CEO and Chairman of the Board of KYBORA Holdings, Inc. "His wealth of experience and profound industry knowledge will play an instrumental role in driving our mission to empower life sciences companies to achieve enduring success. Mr. Zhi's leadership will reinforce our position in China and enhance our capacity to deliver optimal business solutions to clients worldwide."
Drawing on his background in strategic planning, market expansion, and operational excellence, Wang Zhi has successfully led teams and spearheaded initiatives that have resulted in significant growth for multinational firms providing high-quality services to life sciences companies. Over the past five years, Mr. Zhi has notably focused on assisting Chinese life sciences companies in entering the global market. His expertise will be invaluable as KYBORA continues to provide strategic consulting services and facilitate transformative business transactions for its clients.
"I am honored to join KYBORA and contribute to the company's mission of enabling enduring success for life sciences companies," said Wang Zhi. "KYBORA offers an unparalleled combination of global reach and local knowledge to clients worldwide. The Chinese life sciences industry stands to greatly benefit from such an offering, especially during a time when numerous Chinese companies seek global expansion and collaborative agreements with international partners. KYBORA's commitment to delivering optimal business solutions aligns seamlessly with my own passion for driving growth and value creation in the industry. I eagerly anticipate close collaboration with the talented KYBORA team to support our clients' global expansion and strategic objectives."
About KYBORA Life Sciences (Shanghai) Co., Ltd.
KYBORA Life Sciences (Shanghai) Co., Ltd. operates as a subsidiary of KYBORA Holdings Inc., a global advisory firm committed to empowering life sciences companies to achieve enduring success. Through its comprehensive suite of services, encompassing M&A, licensing, fundraising, and strategic consulting, KYBORA equips clients worldwide with the ability to navigate industry complexities and capitalize on growth opportunities. With unwavering dedication to delivering optimal business solutions, KYBORA supports its clients' strategic objectives and contributes to their long-term success.
For more information about KYBORA and its range of business and corporate development transaction services, please visit http://www.kybora.com.
Contact:
Media Relations
KYBORA Life Sciences (Shanghai) Co., Ltd.
Email: [email protected]
Alan Vanderborght, KYBORA, http://www.kybora.com, 1 6099704398, [email protected]
Share this article